๐
Anzupgo
delgocitinib
Dermatitis;Eczema
โ
Authorised
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Anzupgo is indicated for the treatment of moderate to severe chronic hand eczema (CHE)
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/anzupgo